Increased hMSH2 protein expression in glioblastoma multiforme

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Mismatch repair (MMR) proteins, hMSH2 and hMLH1, are key in DNA repair and their absence correlates with microsatellite instability (MSI).
• While MSI is infrequent in astrocytic tumors, altered expression of MMR proteins in gliomas remains understudied.
• Previous reports show varied expression of hMSH2 and hMLH1 in other tumor types, with unclear implications.

Purpose of the Study:

• To investigate the expression patterns of human mismatch repair proteins hMSH2 and hMLH1 in different grades of human astrocytic tumors.
• To compare the expression levels of hMSH2 and hMLH1 between high-grade (glioblastoma multiforme, GBM) and low-grade (astrocytoma, AS) gliomas.

Main Methods:

• Immunohistochemistry was employed to analyze the expression of hMSH2 and hMLH1 proteins.
• Expression levels were quantified and compared between 28 GBM and 27 AS samples.
• Statistical analysis using a two-tailed t-test was performed to determine significant differences.

Main Results:

• A significantly higher expression of hMSH2 protein was observed in GBM (mean 703.07) compared to AS (mean 307.03) (p = 1.47 x 10(-8)).
• No significant difference in hMLH1 expression was found between GBM (mean 543.29) and AS (mean 505.92) (p = 0.67).
• A small subset of both high- and low-grade tumors showed immunonegativity for either hMSH2 or hMLH1.

Conclusions:

• High-grade astrocytic tumors (GBM) exhibit significantly elevated expression of hMSH2 compared to low-grade astrocytomas (AS).
• The functional implications of this hMSH2 overexpression in GBM require further investigation.
• MMR protein expression analysis may offer insights into glioma pathogenesis and progression.